NeuroMetrix, Inc.
NURO
$4.34
-$0.035-0.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.77% | -23.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.77% | -23.64% | |||
| Cost of Revenue | -18.66% | -0.65% | |||
| Gross Profit | 15.00% | -36.57% | |||
| SG&A Expenses | 27.40% | -14.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.05% | -10.33% | |||
| Operating Income | -12.36% | 4.74% | |||
| Income Before Tax | -18.04% | -1.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.04% | -1.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.04% | -1.36% | |||
| EBIT | -12.36% | 4.74% | |||
| EBITDA | -12.82% | 4.78% | |||
| EPS Basic | -17.00% | -0.27% | |||
| Normalized Basic EPS | -11.54% | 5.56% | |||
| EPS Diluted | -17.00% | -0.27% | |||
| Normalized Diluted EPS | -11.54% | 5.56% | |||
| Average Basic Shares Outstanding | 0.89% | 1.09% | |||
| Average Diluted Shares Outstanding | 0.89% | 1.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||